BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6798062)

  • 1. The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase.
    Lippman SM; Mendelsohn G; Trump DL; Wells SA; Baylin SB
    J Clin Endocrinol Metab; 1982 Feb; 54(2):233-40. PubMed ID: 6798062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of histaminase and L-DOPA decarboxylase activity in the transition from C-cell hyperplasia to familial medullary thyroid carcinoma.
    Baylin SB; Mendelsohn G; Weisburger WR; Gann DS; Eggleston JC
    Cancer; 1979 Oct; 44(4):1315-21. PubMed ID: 115572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human medullary thyroid carcinoma in culture provides a model relating growth dynamics, endocrine cell differentiation, and tumor progression.
    Berger CL; de Bustros A; Roos BA; Leong SS; Mendelsohn G; Gesell MS; Baylin SB
    J Clin Endocrinol Metab; 1984 Aug; 59(2):338-43. PubMed ID: 6736207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine-related biochemistry in the spectrum of human lung carcinoma.
    Berger CL; Goodwin G; Mendelsohn G; Eggleston JC; Abeloff MD; Aisner S; Baylin SB
    J Clin Endocrinol Metab; 1981 Aug; 53(2):422-9. PubMed ID: 6114110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell culture.
    Baylin SB; Abeloff MD; Goodwin G; Carney DN; Gazdar AF
    Cancer Res; 1980 Jun; 40(6):1990-4. PubMed ID: 6245807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin and histaminase in C-cell hyperplasia and medullary thyroid carcinoma. A light microscopic and immunohistochemical study.
    Mendelsohn G; Eggleston JC; Weisburger WR; Gann DS; Baylin SB
    Am J Pathol; 1978 Jul; 92(1):35-52. PubMed ID: 99045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of calcitonin immunostaining in medullary carcinoma of the thyroid.
    Saad MF; Ordonez NG; Guido JJ; Samaan NA
    J Clin Endocrinol Metab; 1984 Nov; 59(5):850-6. PubMed ID: 6207198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RT-PCR-based detection of circulating calcitonin-producing cells in patients with advanced medullary thyroid cancer.
    Saller B; Feldmann G; Haupt K; Broecker M; Janssen OE; Roggendorf M; Mann K; Lu M
    J Clin Endocrinol Metab; 2002 Jan; 87(1):292-6. PubMed ID: 11788662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma.
    Boi F; Maurelli I; Pinna G; Atzeni F; Piga M; Lai ML; Mariotti S
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2115-8. PubMed ID: 17405835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease.
    Mendelsohn G; Wells SA; Baylin SB
    Cancer; 1984 Aug; 54(4):657-62. PubMed ID: 6378353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications.
    Baylin SB; Weisburger WR; Eggleston JC; Mendelsohn G; Beaven MA; Abeloff MD; Ettinger DS
    N Engl J Med; 1978 Jul; 299(3):105-10. PubMed ID: 26872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.
    Archier A; Heimburger C; Guerin C; Morange I; Palazzo FF; Henry JF; Schneegans O; Mundler O; Abdullah AE; Sebag F; Imperiale A; Taïeb D
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1027-33. PubMed ID: 26497699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
    Papapetrou PD; Polymeris A
    Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic variables and calcitonin in medullary thyroid cancer.
    Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
    Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience.
    Samulski TD; Livolsi VA; Montone K; Baloch Z
    Pathol Res Pract; 2014 Mar; 210(3):182-5. PubMed ID: 24440099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.